Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Vassar

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
Arthritis Care & Research|October 4, 2022
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United StatesHanano Mamada, Anju Murayama, Sae Kamamoto, et al.
BMJ Oncology|January 31, 2025
Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trialsBrody Dennis, Chance Bratten, Griffin K Hughes, et al.
Pain and Therapy|August 6, 2025
Adherence to CONSORT-PRO Extension Guidelines for Patient-Reported Outcomes in Randomized Controlled Trials Focused on Peripheral Nerve Blocks: A Meta-epidemiological StudyAdam Khan, Tiffany Nguyen, Bryan Dunford, et al.
Cancer Medicine|May 3, 2024
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trialsAdam Khan, Hassan Khan, Griffin K Hughes, et al.
Journal of Clinical Epidemiology|November 14, 2022
Clinical trial data-sharing policies among journals, funding agencies, foundations, and other professional organizations: a scoping reviewAustin L Johnson, J Michael Anderson, Max Bouvette, et al.
Clinical Therapeutics|June 2, 2024
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer IndicationsRafe Hunter Hall, Carson L Wright, Griffin K Hughes, et al.
Contemporary Clinical Trials Communications|September 12, 2024
Assessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysisAlex Hagood, Logan Patrick Corwin, Jay S Modi, et al.
Molecular Cancer Therapeutics|July 10, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Molecular Cancer Therapeutics|August 14, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Annals of Internal Medicine|July 15, 2024
Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of InterventionsRiaz Qureshi, Kevin Naaman, Nicolas G Quan, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
Arthritis Care & Research|October 4, 2022
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United StatesHanano Mamada, Anju Murayama, Sae Kamamoto, et al.
BMJ Oncology|January 31, 2025
Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trialsBrody Dennis, Chance Bratten, Griffin K Hughes, et al.
Pain and Therapy|August 6, 2025
Adherence to CONSORT-PRO Extension Guidelines for Patient-Reported Outcomes in Randomized Controlled Trials Focused on Peripheral Nerve Blocks: A Meta-epidemiological StudyAdam Khan, Tiffany Nguyen, Bryan Dunford, et al.
Cancer Medicine|May 3, 2024
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trialsAdam Khan, Hassan Khan, Griffin K Hughes, et al.
Journal of Clinical Epidemiology|November 14, 2022
Clinical trial data-sharing policies among journals, funding agencies, foundations, and other professional organizations: a scoping reviewAustin L Johnson, J Michael Anderson, Max Bouvette, et al.
Clinical Therapeutics|June 2, 2024
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer IndicationsRafe Hunter Hall, Carson L Wright, Griffin K Hughes, et al.
Contemporary Clinical Trials Communications|September 12, 2024
Assessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysisAlex Hagood, Logan Patrick Corwin, Jay S Modi, et al.
Molecular Cancer Therapeutics|July 10, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Molecular Cancer Therapeutics|August 14, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Annals of Internal Medicine|July 15, 2024
Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of InterventionsRiaz Qureshi, Kevin Naaman, Nicolas G Quan, et al.
Pageof 37